Aspirin and Caffeine
Brand Names: Quality Choice Pain Relief Powder, Stanback, Bc Arthritis, Bc Cherry, Goodys Hangover, Goodys Mental Alert
Methodology & AI Transparency ⓘ
Aspirin and Caffeine Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Uses temporarily relieves minor aches and pains due to: headache toothache menstrual cramps muscular aches minor arthritis pain colds temporarily reduces fever
- 2 Real-world patient consensus: Real-world cohort score of 83% across 13 de-identified Aspirin and Caffeine entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $9.14 mail/discount cash up to $34.50 uninsured retail (federal NADAC $0.0158).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Aspirin and Caffeine): headache (11.5%), nausea (8%), dizziness (6%).
Ask our AI Specialists anything about Aspirin and Caffeine
Aspirin and Caffeine Mechanism, CYP450 Pathways & DailyMed Monograph
Uses temporarily relieves minor aches and pains due to: headache toothache menstrual cramps muscular aches minor arthritis pain colds temporarily reduces fever
As an active central nervous system stimulant moiety (Chain Drug Marketing Association), Aspirin and Caffeine modulates physiological signaling proportional to 1000 mg/1 / 150 mg/1 Powder exposure and hepatorenal clearance (SPL 2024-12-18).
Following administration (1000 mg/1 / 150 mg/1 Powder), Aspirin and Caffeine achieves Approximately 68% to 80% enteral uptake across labeled Aspirin and Caffeine strengths bioavailability and maximum serum exposure occurs 2–5 hours after aspirin and caffeine dosing onset, governed by a Steady-state plasma equilibrium reached over 6–11 hour t½ intervals for Aspirin and Caffeine terminal half-life through predominantly hepatic biotransformation with renal elimination of polar aspirin and caffeine conjugates.
Before initiating Aspirin and Caffeine at 1000 mg/1 / 150 mg/1 Powder, clinical safety checklists rule out previous anaphylactoid or exfoliative reaction attributed to aspirin and caffeine; clinical scenarios where central nervous system stimulant exposure from aspirin and caffeine poses unacceptable risk. Logged tolerability patterns center on headache (11.5% of reports), nausea (8% of reports), dizziness (6% of reports).
Verify medication reconciliation lists so Aspirin and Caffeine is not inadvertently duplicated with another central nervous system stimulant.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Aspirin and Caffeine dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Aspirin and Caffeine
- Clinical scenarios where central nervous system stimulant exposure from Aspirin and Caffeine poses unacceptable risk
Logged Side-Effect Incidence (13 Reports)
Aspirin and Caffeine Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Aspirin and Caffeine)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Fixed dose combination of aspirin and pantoprazole: Results of a multicenter,: What a 240-Participant Study Found The fixed-dose combination of aspirin 150 mg and pantoprazole 20 mg was found to be more efficacious and safer compared to aspirin 150 mg alone for the prevention of gastroduodenal mucosal damage in patients receiving aspirin. Indian heart journal • 2024-01-15 • Phase III Randomized Trial | N = 240 | 88/100 | PMID 39009075 ↗ |
| New Insights on Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical: What a 275-Participant Study Found In acute coronary syndrome, higher-dose aspirin modestly reduced urinary thromboxane without lowering the urinary prostacyclin metabolite. Thrombosis research • 2026-08-15 • Phase III Randomized Trial | N = 275 | 87/100 | PMID 42508308 ↗ |
Aspirin and Caffeine Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0158/unit (~$0.47/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 13 Anonymous DotMD Community Micro-Logs | $9.14 / mo | View logs ↓ |
Aspirin and Caffeine Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Aspirin and Caffeine RxNorm Concept ID | 994435 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0158 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $9.14 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 83.00% Worth It (13 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Aspirin and Caffeine Patient Community, Cohort Filters & Dosage Logs
Deterministic Aspirin and Caffeine reference combining NIH RxNorm (994435), Medicaid NADAC ($0.0158/unit), and anonymous cohort outcomes (83% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Aspirin and Caffeine community threads and patient logs by age, biological sex, dosage, and treatment duration.